Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
Influenza Other Respir Viruses
; 16(6): 1004-1013, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-35770841
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Type of study:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Child
/
Female
/
Humans
Language:
En
Journal:
Influenza Other Respir Viruses
Journal subject:
VIROLOGIA
Year:
2022
Type:
Article
Affiliation country:
Norway